Kuckelman wrote that nothing in our lawsuit would prevent pharmacies from compounding other medicines to meet the needs of US patients. Novo Nordisks press release about the lawsuit mentioned the FDAs notice
In countries like Turkey, where medical aesthetics are highly advanced and affordable, glutathione-based skin whitening treatments attract international patients seeking safe, medically supervised solutions
Significant adverse events, including concerning palpitations or arrhythmias potentially related to semaglutide, should be reported to the FDA MedWatch program to enhance post-marketing safety surveillance
it is banned at all times, in and out of competition, for athletes subject to anti-doping codes, and is not classified under S2 (Peptide Hormones, Growth Factors, and Related Substances), which is reserved for specifically defined peptide hormones and growth factors such as hGH and EPO